Research ArticleExperimental Studies

PAR1 Is a Candidate Target for the Treatment of Peritoneal Dissemination in Gastric Cancer

DAISUKE FUJIMOTO and HIROTOSHI KOBAYASHI
Anticancer Research November 2024, 44 (11) 4857-4867; DOI: https://doi.org/10.21873/anticanres.17311

Article Information

vol. 44 no. 11 4857-4867
DOI 
https://doi.org/10.21873/anticanres.17311
PubMed 
39477325
Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received September 13, 2024
  • Revision received October 3, 2024
  • Accepted October 7, 2024
  • Published online October 29, 2024.
Copyright & Usage 
Copyright © 2024 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Author Information

  1. DAISUKE FUJIMOTO⇑ and
  2. HIROTOSHI KOBAYASHI
  1. Department of Surgery, Teikyo University Hospital Mizonokuchi, Kawasaki, Japan
  1. Correspondence to: Dr. Daisuke Fujimoto, Department of Surgery, Teikyo University Hospital, Mizonokuchi, 5-1-1 Futako, Takatsu, Kawasaki, Kanagawa 213-8507, Japan. E-mail: rui5218{at}gmail.com
View Full Text

Statistics from Altmetric.com

Cited By...

Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools
Reprints and Permissions
PAR1 Is a Candidate Target for the Treatment of Peritoneal Dissemination in Gastric Cancer
DAISUKE FUJIMOTO, HIROTOSHI KOBAYASHI
Anticancer Research Nov 2024, 44 (11) 4857-4867; DOI: 10.21873/anticanres.17311
Twitter logo Facebook logo Mendeley logo

Jump to section

Keywords